Research illustrated that overexpression of ACBD3-AS1 launched accumulation of JAK2, indicating potential comic dialog between ACBD3-AS1 and the JAK2 signaling pathway, which revealed that this transcription factor could unleash tumor booster properties in gastric carcinoma [23]. The gene discussed is JAK2; the disease is gastric carcinoma.